NEW YORK (GenomeWeb) – The GenomeWeb Index dropped around 11 percent in January following declines for the broader stock market, with only one firm in the Index seeing a rise in its stock price.

The decline for the GenomeWeb Index was steeper than the drop for the Dow Jones Industrial Average — which lost nearly 6 percent during the month — and the Nasdaq — which fell nearly 8 percent. But it fared better than the Nasdaq Biotechnology Index, which finished the month 21 percent lower.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Vivek Murthy is no longer the surgeon general of the US, the Associated Press reports.

People around the globe took to the streets to support science — some with signs.

Parents who learn of their increased genetic risk of disease also contend with telling their children about theirs, the New York Times writes.

In PLOS this week: loci linked to body mass index measurements, long non-coding RNA expression and urothelial carcinoma prognosis, and more.